Table V.

Summarized results for the studies with percentage of patients with more than 50% pain reduction as outcome

Pregabalin	Difference in number of patients with 50% pain Reduction(from 100 Patients) ΔE	Cost of treatment in 100 patients(range – USD)	ICER		The consideration based oncomparison of ICER with threshold
			Generic	Brand
300 mg/day [23]	8	(3426–34943)	428	4368	HCE	HCE
450 mg/day [23]	8	(6166–55029)	771	6879	HCE	CE
600 mg/day [23]	9	(6851–47961)	761	5329	HCE	HCE

CE – cost-effective, HCE – highly cost-effective